acne vulgaris.
Conditions
Interventions
Intervention
Treatment of patient would supplement with 0.5 mg/kg/day of oral isotertinoin for 120 days.
Treatment - Drugs
Intervention
Treatment of patient would supplement with 0.5 mg/kg/day of oral isotertinoin for 120 days
Sponsors
Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criterion: patients with acne volgaris on general diet. Exclusion Criteria: patients use others drugs; diabete mellitus; coronary heart disease; metabolic Disease and other serious diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Folic acid. Timepoint: aat the baseline and end of the treatment period (120 day). Method of measurement: by immunoassay method using commercial randox kits.;Homosysteine. Timepoint: at the baseline and end of the treatment period (120 day). Method of measurement: by immunoassay method using commercial Randox kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: at the baseline and end of the treatment period (120 day). Method of measurement: by autoanalyzer using commercial pars azemon kits.;Gama glutamiltransferase. Timepoint: at the baseline and end of the treatment period (120 day). Method of measurement: by autoanalyzer using commercial pars azemon kits.;Alanin trans aminase. Timepoint: at the baseline and end of the treatment period (120 day). Method of measurement: by autoanalyzer using commercial pars azemon kits.;Aspartat trans aminase. Timepoint: at the baseline and end of the treatment period (120 day). Method of measurement: by autoanalyzer using commercial pars azemon kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHassan Ahmadvand
Lorestan University of Medical Sciences
Outcome results
None listed